Wuhan Pharma Chemical Co., Ltd. - China

Welcome to

Wuhan Pharma Chemical Co., Ltd.

Free Member

Wuhan Pharma Chemical Co., Ltd.
China

Company Profile

Company Contact

Name:

Ms. Jane Cao

E-mail:

Send Message

Homepage:

www.farmkemi.com

Mobile Number:

Phone Number:

Fax Number:

Address:

wuhan 430000, Hubei
China

Average User Review

There is no review for this company - Write a review

Registration Date:

May. 24, 2023

Last Updated:

Apr. 18, 2011

Business Nature:

Manufacturing of Chemicals category

Want to contact this company?

Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Wuhan Pharma Chemical Co., Ltd. is located in Wuhan, Hubei, China. We are specialized in mineral chelates, pharmaceutical raw materials, vitamins, amino acids and nutraceutical ingredients. And we also provide custom synthesis to some of our clients.

We built our in-house laboratory to ensure the quality for every batch what we delivered, from grams to kilograms, from LCL to FCL. We also invested a certain sum of funds on the R& D for new items, which enables us to be in good position to offer Custom Manufacturing for those hard-to-make items. We have close relationship to universities in Wuhan and already got great support from them. All these advanced technologies plus our strict management system have already ensured, and will continue to ensure, the first class quality of ingredients for our customers.

We also has good relationship with other partner manufacturers all over the country. Technical sharing and production exchanging sometimes occured among selected partners, most of them have already got GMP certification. We ourselves have already got great achievment on our strong product and will continuously devoted us to the same on other items.

We had already built good business relationships with clients from around the world. We welcome any business enquiries from you.

I am familiar with this company and want to review it.

You have [3] new inquiries.